Edwina Naik
Associate Director, Oncology Research Amgen Inc.
Edwina Naik, Ph.D., is an Associate Director in Oncology Research at Amgen, where she leads cross-functional discovery and development teams advancing large-molecule therapeutics from target validation through lead candidate nomination. Her work spans T-cell engagers, receptor agonists, targeted cytokine therapeutics and ADCs, with expertise in immuno-oncology, cytokine biology and FcγR engineering.
Seminars
Tuesday 15th September 2026
Group Roundtable Discussions
10:30 am
- Roundtable discussions are designed to be interactive, deep dives where attendees break into smaller groups to explore a focused topic through candid, peer-led conversation. Each group will exchange experiences, challenges, and practical insights before reconvening to share key takeaways with the wider audience and with the conversation being facilitated by our seminar day leaders.
Tuesday 15th September 2026
Advancing Next-Generation TCEs with AI-Guided Drug Design
9:30 am
- Exploring why new TCE designs such as dual targeting or avidity-based formats are required to overcome the challenges to TCE efficacy posed by solid tumors
- Building a deeper understanding of the affinity and epitope requirements that maximize tumor selectivity which will be critical to unlock the potential of dual targeting TCEs
- AI integration is profoundly impacting therapeutic discovery, enabling delivery of optimized candidates at breakthrough speed
